Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

56.22
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
26.26
Today|||52-Week Range
57.57
+104.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues5.4M16.3M35.0M46.0M
 
 
 
 
 
Cost of Goods Sold130.0K252.0K534.0K1.3M
 
 
 
 
 
Depreciation And Amortization1.7M1.6M1.8M2.6M
 
 
 
 
 
 
Operating ExpensesGross Income3.6M14.5M32.7M42.1M
 
 
 
 
 
General Expenses92.0M53.5M90.7M62.4M
 
 
 
 
 
Research And Development70.7M29.0M58.8M34.2M
 
 
 
 
 
Total Operating Expenses93.8M55.4M93.0M66.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-88.4M-39.0M-58.0M-20.3M
 
 
 
 
 
Extraordinary Credit0.00125.0M0.000.00
 
 
Extraordinary Charge0.00-236.0K-5.4M-25.6M
 
 
 
 
Interest Expense On Debt57.0K------
 
 
Other Expenses0.00335.0K184.0K184.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-88.5M86.1M-63.2M-45.7M
 
 
 
 
 
Income Taxes0.00-2.0M-109.0K-2.0M
 
 
 
 
Net Income-88.5M84.1M-63.0M-47.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS54.6M54.9M55.0M61.5M
 
 
 
 
 
Shares To Calculate EPS Diluted54.6M56.0M55.0M61.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.62$1.50-$1.15-$0.78
 
 
 
 
 
EPS Diluted-$1.62$1.50-$1.15-$0.78